LBX Pharmacy Chain Joint Stock Company

SHSE:603883 Stock Report

Market Cap: CN¥13.8b

LBX Pharmacy Chain Balance Sheet Health

Financial Health criteria checks 4/6

LBX Pharmacy Chain has a total shareholder equity of CN¥7.5B and total debt of CN¥4.0B, which brings its debt-to-equity ratio to 53.4%. Its total assets and total liabilities are CN¥21.2B and CN¥13.7B respectively. LBX Pharmacy Chain's EBIT is CN¥1.4B making its interest coverage ratio 14.8. It has cash and short-term investments of CN¥2.1B.

Key information

53.4%

Debt to equity ratio

CN¥4.03b

Debt

Interest coverage ratio14.8x
CashCN¥2.10b
EquityCN¥7.55b
Total liabilitiesCN¥13.66b
Total assetsCN¥21.21b

Recent financial health updates

Recent updates

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 06
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Sep 02
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Jul 03
Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

Jun 08
Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

May 21
LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Apr 22
There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Financial Position Analysis

Short Term Liabilities: 603883's short term assets (CN¥8.6B) do not cover its short term liabilities (CN¥10.1B).

Long Term Liabilities: 603883's short term assets (CN¥8.6B) exceed its long term liabilities (CN¥3.5B).


Debt to Equity History and Analysis

Debt Level: 603883's net debt to equity ratio (25.6%) is considered satisfactory.

Reducing Debt: 603883's debt to equity ratio has increased from 34.6% to 53.4% over the past 5 years.

Debt Coverage: 603883's debt is well covered by operating cash flow (63.4%).

Interest Coverage: 603883's interest payments on its debt are well covered by EBIT (14.8x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 16:21
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LBX Pharmacy Chain Joint Stock Company is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Qianyi LiChina International Capital Corporation Limited
Yong Jian LiChina Merchants Securities Co. Ltd.